Angiotensin II receptor antagonists

Details for Australian Patent Application No. 2007334522 (hide)

Owner NiCox S.A. Merck & Co., Inc.

Inventors Almirante, Nicoletta; Nargund, Ravi P.; Ali, Amjad; Lo, Michael Man-Chu; Franklin, Chris; Sebhat, Iyassu K.; Stefanini, Silvia; Storoni, Laura

Agent Peter Maxwell & Associates

Pub. Number AU-B-2007334522

PCT Pub. Number WO2008/076246

Priority 60/874,630 13.12.06 US

Filing date 11 December 2007

Wipo publication date 26 June 2008

Acceptance publication date 15 March 2012

International Classifications

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/076246 Priority application(s): WO2008/076246

8 March 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Angiotensin II receptor antagonists 2008

15 March 2012 Application Accepted

  Published as AU-B-2007334522

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334527-Biocidal composition and method for treating recirculating water systems

2007334521-Angiotensin II receptor antagonists